Ligand Pharmaceuticals
LGND
LGND
265 hedge funds and large institutions have $3.04B invested in Ligand Pharmaceuticals in 2017 Q2 according to their latest regulatory filings, with 34 funds opening new positions, 103 increasing their positions, 87 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
16% more capital invested
Capital invested by funds: $2.61B → $3.04B (+$424M)
4% more funds holding
Funds holding: 256 → 265 (+9)
1.81% more ownership
Funds ownership: 189.26% → 191.07% (+1.8%)
Holders
265
Holding in Top 10
7
Calls
$26.7M
Puts
$5.51M
Top Buyers
| 1 | +$72.3M | |
| 2 | +$23.9M | |
| 3 | +$12.5M | |
| 4 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$12.3M |
| 5 |
CM
Castleark Management
Chicago,
Illinois
|
+$9.55M |
Top Sellers
| 1 | -$52.8M | |
| 2 | -$16.9M | |
| 3 | -$12.5M | |
| 4 |
AL
AJO LP
Philadelphia,
Pennsylvania
|
-$10.5M |
| 5 |
State of New Jersey Common Pension Fund D
Trenton,
New Jersey
|
-$8.5M |